Squarepoint
FLNA

Squarepoint’s Filana Therapeutics FLNA Stock Holding History

Squarepoint’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$379K Buy
+318,380
New +$454K ﹤0.01% 3651
2025
Q4 		– Sell
-12,396
Closed -$39.7K – 4809
2025
Q3 		$36.1K Sell
12,396
-94,073
-88% -$216K ﹤0.01% 4256
2025
Q2 		$193K Buy
106,469
+41,345
+63% +$73.6K ﹤0.01% 3988
2025
Q1 		$97.7K Buy
65,124
+11,034
+20% +$27.8K ﹤0.01% 4227
2024
Q4 		$128K Buy
54,090
+43,757
+423% +$768K ﹤0.01% 4636
2024
Q3 		$304K Buy
+10,333
New +$238K ﹤0.01% 3435
2023
Q3 		– Sell
-32,755
Closed -$803K – 4187
2023
Q2 		$803K Buy
+32,755
New +$789K ﹤0.01% 2329
2022
Q4 		– Sell
-20,995
Closed -$878K – 3549
2022
Q3 		$878K Buy
+20,995
New +$567K ﹤0.01% 1851
2022
Q2 		– Sell
-14,139
Closed -$525K – 3307
2022
Q1 		$525K Buy
+14,139
New +$599K ﹤0.01% 1976
2021
Q4 		– Sell
-36,405
Closed -$2.26M – 3477
2021
Q3 		$2.26M Buy
36,405
+29,710
+444% +$2.48M 0.01% 1145
2021
Q2 		$572K Sell
6,695
-45,090
-87% -$2.42M ﹤0.01% 2032
2021
Q1 		$2.33M Sell
51,785
-46,960
-48% -$1.85M 0.01% 986
2020
Q4 		$673K Buy
+98,745
New +$882K 0.01% 1590
2020
Q3 		– Sell
-18,554
Closed -$57K – 2799
2020
Q2 		$57K Buy
+18,554
New +$84.2K ﹤0.01% 2087
2015
Q3 		– Sell
-5,886
Closed -$71K – 556
2015
Q2 		$71K Buy
+5,886
New +$80.6K 0.02% 415

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Squarepoint's FLNA Position: Q2 2026 in Review

Squarepoint opened a new position in Filana Therapeutics (FLNA) in Q2 2026: 318,380 shares worth $379K. The stake represents ﹤0.01% of the portfolio and ranks #3651 among its holdings. This is a return to the name: Squarepoint previously reported a position in FLNA as recently as Q3 2025.

Squarepoint first reported a position in FLNA in Q2 2015 and has held it in 15 quarters since. The position peaked at $2.33M in Q1 2021. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Squarepoint held 318,380 shares of Filana Therapeutics worth $379K as of Q2 2026.
  • Filana Therapeutics was a new Squarepoint position in Q2 2026.
  • Filana Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3651 holding.
  • Squarepoint first reported a position in Filana Therapeutics in Q2 2015 and has held it in 15 quarters since.
  • Squarepoint's Filana Therapeutics position peaked at $2.33M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.